PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer

BACKGROUND: Personalized and effective treatments for pancreatic ductal adenocarcinoma (PDAC) continue to remain elusive. Novel clinical trial designs that enable continual and rapid evaluation of novel therapeutics are needed. Here, we describe a platform clinical trial to address this unmet need....

Descripción completa

Detalles Bibliográficos
Autores principales: Douglas, Julia E., Liu, Suyu, Ma, Junsheng, Wolff, Robert A., Pant, Shubham, Maitra, Anirban, Tamm, Eric P., Bhosale, Priya, Katz, Matthew H. G., Varadhachary, Gauri R., Koay, Eugene J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722115/
https://www.ncbi.nlm.nih.gov/pubmed/34980020
http://dx.doi.org/10.1186/s12885-021-09095-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722115/
https://www.ncbi.nlm.nih.gov/pubmed/34980020
http://dx.doi.org/10.1186/s12885-021-09095-7

Ejemplares similares